Vademecum Internacional icon

2.9.0 by VIDAL VADEMECUM SPAIN


Oct 28, 2024

About Vademecum Internacional

Your leading pharmacological guide in Spanish.

Vademecum Internacional is a complete paid application where you will find the most consulted Pharmacological Guide in Spanish in the world, updated weekly throughout the subscription period.

In addition, you will have, in the same application, the Interactions module and the search for International Equivalences with the aim of promoting the rational use of the medication.

FREE CONTENT:

- Vademecum Surveillance

- Supply problems

- Update of monograph of active ingredients (AP)

- Security news and alerts

PAYMENT CONTENT:

VADEMECUM INTERNATIONAL PHARMACOLOGICAL GUIDE MODULE

It will allow you to search for pharmacological information by brand name, PA or therapeutic indication in more than 45 countries (*).

You can consult the ATC Monograph for each product, detailed with dosage, therapeutic indications, warnings and precautions, contraindications, adverse reactions and interactions. In addition to pharmacovigilance alerts, breastfeeding, pregnancy, kidney and liver failure, photosensitivity, effects on driving vehicles.

You will be able to consult the trademarks of Spain (more than 18,000 medicines constantly updated) and more than 45 countries, with access to additional regulatory and administrative information for:

- Argentina (more than 11,000 medications)

- Chile (more than 13,000 medications)

- Mexico (more than 16,500 medications)

- Peru (more than 18,500 medications)

- Uruguay (more than 5,000 medications)

In addition, for Spain, you will have updated packaging information, including prices and financing, product visualization (ES and MX), marketing and authorization status, national and barcode codes, and dispensing and conservation information.

INTERACTIONS MODULE

You will be able to calculate interactions (based on evidence) between 2 or more medications.

For this calculation, the composition of the medications, their route of administration and dosage are taken into account, thus avoiding the saturation of alerts.

Analyzing a prescription is as fast as selecting, analyzing and reviewing.

Each interaction is described with the sections of “severity” (coded according to 4 levels of severity: Take into account, Caution for use, Association not recommended, Contraindication), “risk and mechanism” and “advice”, providing the professional with the support of Vademecum in their decision making.

This application is intended for health professionals and should not be used as a substitute for consulting a doctor. Clinical decisions are the exclusive responsibility of the treating physician. Vademecum Internacional has taken the utmost care in verifying the data and transcribing it, however, there is the possibility of inadvertent errors.

What's New in the Latest Version 2.9.0

Last updated on Oct 28, 2024

¡Tu aplicación Vademecum Internacional sigue evolucionando!
¿Cuáles son las novedades?
• Un nuevo formato de contenido visual (fotos o vídeos) llamado "Story", disponible por tiempo limitado, podrá serte propuesto en función de tu perfil.
• Mejora de la selección de países, dando prioridad a los más populares en las listas dedicadas.
• Navegación optimizada en la barra de búsqueda general para una experiencia más fluida.
¡Gracias por utilizar Vademecum Internacional!

Translation Loading...

Additional APP Information

Latest Version

Request Vademecum Internacional Update 2.9.0

Uploaded by

Mari Woo

Requires Android

Android 5.0+

Available on

Get Vademecum Internacional on Google Play

Show More

Vademecum Internacional Screenshots

Comment Loading...
Languages
Searching...
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Subscribed Successfully!
You're now subscribed to APKPure.
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Success!
You're now subscribed to our newsletter.